HCC
Hirtle Callaghan & Co’s ResMed RMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,204
| Closed | -$1.08M | – | 100 |
|
|
2022
Q4 | $1.08M | Sell |
5,204
-407
| -7% | -$84.7K | 0.07% | 68 |
|
|
2022
Q3 | $1.23M | Buy |
5,611
+3,267
| +139% | +$713K | 0.09% | 64 |
|
|
2022
Q2 | $491K | Buy |
2,344
+848
| +57% | +$178K | 0.03% | 82 |
|
|
2022
Q1 | $363K | Buy |
1,496
+430
| +40% | +$104K | 0.02% | 101 |
|
|
2021
Q4 | $278K | Buy |
+1,066
| New | +$278K | 0.01% | 79 |
|
|
2019
Q1 | – | Sell |
-6,900
| Closed | -$786K | – | 122 |
|
|
2018
Q4 | $786K | Hold |
6,900
| – | – | 0.07% | 40 |
|
|
2018
Q3 | $796K | Hold |
6,900
| – | – | 0.07% | 45 |
|
|
2018
Q2 | $715K | Hold |
6,900
| – | – | 0.07% | 45 |
|
|
2018
Q1 | $679K | Hold |
6,900
| – | – | 0.06% | 49 |
|
|
2017
Q4 | $584K | Hold |
6,900
| – | – | 0.05% | 54 |
|
|
2017
Q3 | $531K | Buy |
+6,900
| New | +$531K | 0.05% | 56 |
|
|
2016
Q4 | – | Sell |
-6,900
| Closed | -$447K | – | 195 |
|
|
2016
Q3 | $447K | Hold |
6,900
| – | – | 0.09% | 58 |
|
|
2016
Q2 | $436K | Hold |
6,900
| – | – | 0.08% | 55 |
|
|
2016
Q1 | $399K | Buy |
+6,900
| New | +$399K | 0.07% | 55 |
|
|
2015
Q1 | – | Sell |
-7,700
| Closed | -$432K | – | 292 |
|
|
2014
Q4 | $432K | Hold |
7,700
| – | – | 0.1% | 122 |
|
|
2014
Q3 | $379K | Hold |
7,700
| – | – | 0.06% | 134 |
|
|
2014
Q2 | $390K | Hold |
7,700
| – | – | 0.05% | 167 |
|
|
2014
Q1 | $344K | Hold |
7,700
| – | – | 0.06% | 169 |
|
|
2013
Q4 | $363K | Buy |
7,700
+800
| +12% | +$37.7K | 0.05% | 170 |
|
|
2013
Q3 | $364K | Buy |
+6,900
| New | +$364K | 0.06% | 165 |
|